Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers von Lips, E H, Mulder, L, Oonk, A, van der Kolk, L E, Hogervorst, F B L, Imholz, A L T, Wesseling, J, Rodenhuis, S, Nederlof, P M

Volltext

An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients von Vollebergh, M.A., Lips, E.H., Nederlof, P.M., Wessels, L.F.A., Schmidt, M.K., van Beers, E.H., Cornelissen, S., Holtkamp, M., Froklage, F.E., de Vries, E.G.E., Schrama, J.G., Wesseling, J., van de Vijver, M.J., van Tinteren, H., de Bruin, M., Hauptmann, M., Rodenhuis, S., Linn, S.C.

Volltext

A multiplex PCR predictor for aCGH success of FFPE samples von VAN BEERS, E. H, JOOSSE, S. A, LIGTENBERG, M. J, FLES, R, HOGERVORST, F. B. L, VERHOEF, S, NEDERLOF, P. M

Volltext

Neoadjuvant chemotherapy in ER+ HER2− breast cancer: response prediction based on immunohistochemical and molecular characteristics von Lips, E. H., Mulder, L., de Ronde, J. J., Mandjes, I. A. M., Vincent, A., Vrancken Peeters, M. T. F. D., Nederlof, P. M., Wesseling, J., Rodenhuis, S.

Volltext

Indicators of homologous recombination deficiency in breast cancer and association with response to neoadjuvant chemotherapy von Lips, E.H., Mulder, L., Hannemann, J., Laddach, N., Vrancken Peeters, M.T.F.D., van de Vijver, M.J., Wesseling, J., Nederlof, P.M., Rodenhuis, S.

Volltext

The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs von van der Velden, D. L., Hoes, L. R., van der Wijngaart, H., van Berge Henegouwen, J. M., van Werkhoven, E., Roepman, P., Schilsky, R. L., de Leng, W. W. J., Huitema, A. D. R., Nuijen, B., Nederlof, P. M., van Herpen, C. M. L., de Groot, D. J. A., Devriese, L. A., Hoeben, A., de Jonge, M. J. A., Chalabi, M., Smit, E. F., de Langen, A. J., Mehra, N., Labots, M., Kapiteijn, E., Sleijfer, S., Cuppen, E., Verheul, H. M. W., Gelderblom, H., Voest, E. E.

Volltext

Molecular Tumor Boards: current practice and future needs von van der Velden, D.L., van Herpen, C.M.L., van Laarhoven, H.W.M., Smit, E.F., Groen, H.J.M., Willems, S.M., Nederlof, P.M., Langenberg, M.H.G., Cuppen, E., Sleijfer, S., Steeghs, N., Voest, E.E.

Volltext

Goblet cell carcinoid of the appendix: a specific type of carcinoma von Van Eeden, S, Offerhaus, G J A, Hart, A A M, Boerrigter, L, Nederlof, P M, Porter, E, Van Velthuysen, M-L F

Volltext

Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach von GILLE, J. J. P, HOGERVORST, F. B. L, MCELGUNN, C. J, SCHOUTEN, J. P, MENKO, F. H, PALS, G, WIJNEN, J. Th, VAN SCHOOTEN, R. J, DOMMERING, C. J, MEIJER, G. A, CRAANEN, M. E, NEDERLOF, P. M, DE JONG, D

Volltext

A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patients von Didraga, M. A., van Beers, E. H., Joosse, S. A., Brandwijk, K. I. M., Oldenburg, R. A., Wessels, L. F. A., Hogervorst, F. B. L., Ligtenberg, M. J., Hoogerbrugge, N., Verhoef, S., Devilee, P., Nederlof, P. M.

Volltext

Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method von HOGERVORST, Frans B. L, NEDERLOF, Petra M, KLUIJT, Irma, DOMMERING, Charlotte, VERHOEF, Senno, SCHOUTEN, Jan P, VAN'T VEER, Laura J, PALS, Gerard, GILLE, Johan J. P, MCELGUNN, Cathal J, GRIPPELING, Maartje, PRUNTEL, Roelof, REGNERUS, Rein, VAN WELSEM, Tibor, VAN SPAENDONK, Resie, MENKO, Fred H

Volltext

Senescence bypass screen identifies TBX2 , which represses Cdkn2a ( p19 ARF ) and is amplified in a subset of human breast cancers von van Lohuizen, Maarten, Jacobs, Jacqueline J.L, Keblusek, Petra, Robanus-Maandag, Els, Kristel, Petra, Lingbeek, Merel, Nederlof, Petra M, van Welsem, Tibor, van de Vijver, Marc J, Koh, Eugene Y, Daley, George Q

Volltext

Nuclear Localization Signals of Human and Thermoplasma Proteasomal α Subunits are Functional in vitro von Nederlof, P M, Wang, H R, Baumeister, W

Volltext

A tumour with a neuroendocrine and papillary serous component: two or a pair? von van Eeden, S, Nederlof, P M, Taal, B G, Offerhaus, G J A, van Velthuysen, M-L F

Volltext

Quality control in diagnostic molecular pathology in the Netherlands; proficiency testing for patient identification in tissue samples von Thunnissen, F B J M, Tilanus, M G J, Ligtenberg, M J L, Nederlof, P M, Dinjens, W N M, Meulemans, E, Van den Brule, A J C, van Noesel, C J M, de Leeuw, W J F, Schuuring, E

Volltext

Thick-section fluorescence in situ hybridization on formalin-fixed, paraffin-embedded archival tissue provides a histogenetic profile von Thompson, CT, LeBoit, PE, Nederlof, PM, Gray, JW

Volltext

Nationwide evaluation of mutation-tailored anti-EGFR therapy selection in patients with colorectal cancer in daily clinical practice von Steeghs, Elisabeth M P, Vink, Geraldine R, Elferink, Marloes A G, Voorham, Quirinus J M, Gelderblom, Hans, Nagtegaal, Iris D, Grünberg, Katrien, Ligtenberg, Marjolijn J L, Drillenburg, P, Nijhuis, E W P, van de Vijver, M J, van Noesel, C J, Bloemena, E, Heideman, D A M, Radonic, T, Thunissen, E, Nederlof, P M, Meijer, G A, Monkhorst, K, Doornewaard, H, Dijk, M C R F van, Ruijter, E, Duthoi, K, Meijers, C, van de Brule, A J C, Nooijen, P T G A, Bot, F J, Hazalbag, H M, Clahsen, P, van Nederveen, F H, Westenend, P J, Jeuken, J W M, Ahsmann, E J M, Meulbroek, P, Timens, W, Schuuring, E, van Kempen, L C, Geuken, W, Bulkmans, N W J, Bellot, F E, Clarijs, R, Riemersma, S, van der Geize, R, Meijer, J, van Slooten, H J, Kibbelaar, R E, van der Logt, E M J, van Wezel, T, Morreau, H, Bovee, J V M G, Zur Hausen, A, Speel, E J M, de Bruin, P C, Huijsmans, C J, Dusseljee, S, Willems, R W, Prinsen, C F, Zomer, S, van Kemenade, F J, Dinjens, W N M, Geurts-Giele, W R R, van der Valk, H, Smits, A J J, Hoogduin, K J, Kliffen, M, den Bakker, M A, Stavast, J, van Diest, P J, de Leng, W W J, de Bruïne, A P, Hinrichs, J W J, Meischl, C, Gaal, J, Niemantsverdriet, M

Volltext

187PHigh dose neo-adjuvant chemotherapy in triple-negative breast cancer with evidence of homologous recombination deficiency (HRD) von Vliek, S B, Van Werkhoven, E, Mandjes, I, Westphal, T, Lips, E H, Mulder, L, Loo, C, Russel, N, Holtkamp, M, Schot, M, Baars, J, Karger, M, Honkoop, A H, Bos, M E M M, Imholz, A L T, Vrijaldenhoven, S, Dezentje, V, Nederlof, P M, Linn, S C

Volltext

In situ hybridization with fluoresceinated DNA von WIEGANT, J, RIED, T, NEDERLOF, P. M, VAN DER PLOEG, M, TANKE, H. J, RAAP, A. K

Volltext

Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas von Robanus-Maandag, Els C, Bosch, Cathy AJ, Kristel, Petra M, Hart, Augustinus AM, Faneyte, Ian F, Nederlof, Petra M, Peterse, Johannes L, van de Vijver, Marc J

Volltext